Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly L Olino

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Surgical Clinics of North America|March 23, 2017
Gastric NeoplasmsKelly L Olino, Douglas S Tyler
Frontiers in Oncology|February 21, 2024
Immunotherapy utilization in stage IIIA melanoma: less may be moreAlexander E Frey, Daniel M Kerekes, Sajid A Khan, et al.
JAMA Oncology|January 4, 2024
Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the USDaniel M Kerekes, Alexander E Frey, Elizabeth H Prsic, et al.
Cancer Research|September 10, 2009
Integrin alpha2 mediates selective metastasis to the liverKiyoshi Yoshimura, Kristen F Meckel, Lindsay S Laird, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Surgical Clinics of North America|March 23, 2017
Gastric NeoplasmsKelly L Olino, Douglas S Tyler
Frontiers in Oncology|February 21, 2024
Immunotherapy utilization in stage IIIA melanoma: less may be moreAlexander E Frey, Daniel M Kerekes, Sajid A Khan, et al.
JAMA Oncology|January 4, 2024
Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the USDaniel M Kerekes, Alexander E Frey, Elizabeth H Prsic, et al.
Cancer Research|September 10, 2009
Integrin alpha2 mediates selective metastasis to the liverKiyoshi Yoshimura, Kristen F Meckel, Lindsay S Laird, et al.
Pageof 1